Marta Morawska

843 total citations
37 papers, 418 citations indexed

About

Marta Morawska is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Marta Morawska has authored 37 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Hematology. Recurrent topics in Marta Morawska's work include Multiple Myeloma Research and Treatments (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Peptidase Inhibition and Analysis (6 papers). Marta Morawska is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Peptidase Inhibition and Analysis (6 papers). Marta Morawska collaborates with scholars based in Poland, Czechia and United Kingdom. Marta Morawska's co-authors include Norbert Grząśko, Marek Hus, Kinga K. Borowicz, J. Lewkowski, Jarogniew J. Łuszczki, Stanisław J. Czuczwar, Piotr Rychter, Anna Dmoszyńska, Diana Rogacz and Andrzej Pluta and has published in prestigious journals such as Blood, Chemosphere and International Journal of Cancer.

In The Last Decade

Marta Morawska

35 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Morawska Poland 12 133 120 115 69 51 37 418
Shuang Hu China 11 54 0.4× 133 1.1× 35 0.3× 29 0.4× 42 0.8× 35 425
Runxia Gu China 10 64 0.5× 132 1.1× 111 1.0× 36 0.5× 13 0.3× 41 412
Celeste Decker United States 17 39 0.3× 82 0.7× 18 0.2× 83 1.2× 22 0.4× 21 685
Ndeye Diop-Bove United States 10 49 0.4× 231 1.9× 101 0.9× 30 0.4× 87 1.7× 10 636
David Allsup United Kingdom 14 95 0.7× 185 1.5× 74 0.6× 150 2.2× 11 0.2× 54 618
Eriko Yasuda Japan 17 51 0.4× 151 1.3× 11 0.1× 41 0.6× 30 0.6× 33 816
Koji Arai Japan 10 95 0.7× 224 1.9× 14 0.1× 20 0.3× 21 0.4× 22 395
J.L. Misset France 13 119 0.9× 121 1.0× 357 3.1× 120 1.7× 45 0.9× 39 733
Emily Chew Singapore 4 168 1.3× 27 0.2× 94 0.8× 23 0.3× 85 1.7× 7 419
Sara Santos Franco United Kingdom 8 73 0.5× 154 1.3× 78 0.7× 19 0.3× 31 0.6× 10 380

Countries citing papers authored by Marta Morawska

Since Specialization
Citations

This map shows the geographic impact of Marta Morawska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Morawska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Morawska more than expected).

Fields of papers citing papers by Marta Morawska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Morawska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Morawska. The network helps show where Marta Morawska may publish in the future.

Co-authorship network of co-authors of Marta Morawska

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Morawska. A scholar is included among the top collaborators of Marta Morawska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Morawska. Marta Morawska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiełbus, Michał, Joanna Zaleska, Ewa Wawrzyniak, et al.. (2024). Increased abundance of Firmicutes and depletion of Bacteroidota predicts poor outcome in chronic lymphocytic leukemia. Oncology Letters. 28(5). 552–552. 4 indexed citations
2.
Morawska, Marta, Michał Kiełbus, Agnieszka Karczmarczyk, et al.. (2024). Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myeloma. Cancer Genetics. 288-289. 118–125.
3.
Dreyling, Martin, Jiřı́ Mayer, David Belada, et al.. (2024). High-Risk Subgroups and MRD: An Updated Analysis of the Phase 3 ECHO Trial of Acalabrutinib with Bendamustine/Rituximab in Previously Untreated Mantle Cell Lymphoma. Blood. 144(Supplement 1). 1626–1626. 2 indexed citations
4.
Drozd‐Sokołowska, Joanna, Ewa Paszkiewicz‐Kozik, Marta Morawska, et al.. (2023). Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group. Annals of Hematology. 102(8). 2119–2126. 4 indexed citations
5.
Morawska, Marta, Jadwiga Dwilewicz‐Trojaczek, Tomasz Stompór, et al.. (2023). A Stepwise Screening Protocol for Multiple Myeloma. Journal of Clinical Medicine. 12(4). 1345–1345. 1 indexed citations
6.
Kalicińska, Elżbieta, Monika Biernat, Justyna Rybka, et al.. (2021). Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study. Journal of Clinical Medicine. 10(19). 4373–4373. 21 indexed citations
7.
Karczmarczyk, Agnieszka, Agnieszka Bojarska−Junak, Waldemar Tomczak, et al.. (2020). Cofilin-1 Maintains Prosurvival Signaling in Chronic Lymphocytic Leukemia Cells. Anticancer Research. 40(11). 6327–6335. 2 indexed citations
8.
Długosz‐Danecka, Monika, Wojciech Jurczak, Marta Morawska, et al.. (2018). Efficacy and safety of the obinutuzumab-chlorambucil combination in the frontline treatment of elderly CLL patients with comorbidities – Polish Adult Leukemia Group (PALG) real-life analysis. Polskie Archiwum Medycyny Wewnętrznej. 128(7-8). 421–426. 4 indexed citations
9.
Paszkiewicz‐Kozik, Ewa, Monika Długosz‐Danecka, Paweł Robak, et al.. (2017). Subcutaneous Compared to Intravenous Administration of Rituximab Plus CHOP in Patients with Diffuse Large B-Cell Lymphoma — a Study By the Polish Lymphoma Research Group. Blood. 130. 5217–5217. 2 indexed citations
10.
Szmit, Sebastian, Wojciech Jurczak, Jan Maciej Zaucha, et al.. (2017). Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders. International Journal of Cardiology. 235. 147–153. 10 indexed citations
11.
12.
Lewkowski, J., Marta Morawska, Piotr Rychter, et al.. (2017). Evaluation of ecotoxicological impact of new pyrrole-derived aminophosphonates using selected bioassay battery. Ecotoxicology. 26(7). 914–929. 10 indexed citations
13.
Borowicz, Kinga K., et al.. (2015). Effect of cholecalciferol on the anticonvulsant action of some second generation antiepileptic drugs in the mouse model of maximal electroshock. Pharmacological Reports. 67(5). 875–880. 15 indexed citations
14.
Grząśko, Norbert, Marta Morawska, & Marek Hus. (2014). Optimizing the Treatment of Patients With Multiple Myeloma and Renal Impairment. Clinical Lymphoma Myeloma & Leukemia. 15(4). 187–198. 23 indexed citations
15.
Morawska, Marta, et al.. (2014). Therapy‐related peripheral neuropathy in multiple myeloma patients. Hematological Oncology. 33(4). 113–119. 61 indexed citations
16.
17.
Hus, Marek, Norbert Grząśko, Andrzej Pluta, et al.. (2011). Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma. Annals of Hematology. 90(10). 1161–1166. 49 indexed citations
18.
19.
Borowicz, Kinga K., et al.. (2007). Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock. European Journal of Pharmacology. 573(1-3). 111–115. 43 indexed citations
20.
Sekuła, W., et al.. (1997). A comparison of the food and health patterns in Greece and in Poland. Żywienie Człowieka i Metabolizm. 24(24). 3–16. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuang Hu Breakdown of academic impact, for papers by Runxia Gu Breakdown of academic impact, for papers by Celeste Decker Breakdown of academic impact, for papers by Ndeye Diop-Bove Breakdown of academic impact, for papers by David Allsup Breakdown of academic impact, for papers by Eriko Yasuda Breakdown of academic impact, for papers by Koji Arai Breakdown of academic impact, for papers by J.L. Misset Breakdown of academic impact, for papers by Emily Chew Breakdown of academic impact, for papers by Sara Santos Franco
Rankless by CCL
2026